The object
Mehmet Toner co-developed the CTC microchip, a microfluidic device that isolates rare circulating tumor cells from a blood sample for cancer research and diagnostics. Massachusetts General Hospital documents the chip’s early cancer-detection work, and a 2025 interview describes Toner’s continuing microfluidic cancer-diagnostic work.
01
What Mehmet did
Co-developed the CTC microchip, a microfluidic device that captures circulating tumor cells from blood samples.
02
Why it matters
The CTC chip made rare tumor cells accessible through a minimally invasive blood sample, advancing liquid-biopsy research and cancer monitoring.
03
Living-status check
A September 9, 2025 interview and award report discusses Toner’s microfluidic cancer-diagnostic devices.